Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus

被引:9
|
作者
Makita, Kenji [1 ]
Kitazawa, Riko [1 ]
Semba, Shuho [2 ]
Fujiishi, Koto [1 ]
Nakagawa, Miku [1 ]
Haraguchi, Ryuma [1 ]
Kitazawa, Sohei [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Div Mol Pathol, Toon City, Ehime 7910295, Japan
[2] Kobe Univ, Grad Sch Med, Div Pathol, Kobe, Hyogo 6500017, Japan
关键词
Barretti's esophagus; Caudal type homebox transcription factor 2; Intestinal metaplasia; Promoter hypermethylation; GENE-EXPRESSION; MARKER; ADENOCARCINOMAS; MORPHOLOGY; ORIGIN;
D O I
10.3748/wjg.v19.i4.536
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To examine how the expression of caudal type homebox transcription factor 2 (Cdx2) is regulated in the development of malignancy in Barrett's esophagus. METHODS: Cdx2, mucin (MUC) series (MUC2, MUC5AC and MUC6), p53 and E-cadherin expression in Barrett's esophagus and adenocarcinoma specimens were examined by immunostaining. Isolated clusters of cells from (1) MUC2 and Cdx2-positive intestinal metaplastic mucosa; (2) MUC5AC and MUC6-positive, and MUC2 and Cdx2-negative high-grade dysplasia (HD), or intramucosal adenocarcinoma (IMC); and (3) MUC5AC, MUC6 and Cdx2-positive poorly-differentiated invasive adenocarcinoma (PDA) were analyzed by methylation-specific polymerase chain reaction using sets of primers for detecting methylation status of the Cdx2 gene. RESULTS: Most of the non-neoplastic Barrett's esophageal mucosa showing intestinal-type metaplasia with or without low-grade dysplasia was positive for E-cadherin, MUC series and Cdx2, but negative for p53. A portion of the low-grade to HD was positive for E-cadherin, MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. The definite IMC area was strongly positive for MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. Methylation of the Cdx2 promoter was not observed in intestinal metaplasia, while hypermethylation of part of its promoter was observed in hot dipped and IMC. Hypermethylation of a large fraction of the Cdx2 promoter was observed in PDA. CONCLUSION: Cdx2 expression is restored irrespective of the methylation status of its promoter. Apparent positive immunohistochemical results can be a molecular mark for gene silencing memory. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:536 / 541
页数:6
相关论文
共 50 条
  • [1] Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus
    Kenji Makita
    Riko Kitazawa
    Shuho Semba
    Koto Fujiishi
    Miku Nakagawa
    Ryuma Haraguchi
    Sohei Kitazawa
    [J]. World Journal of Gastroenterology, 2013, (04) : 536 - 541
  • [2] Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus
    Kuester, Doerthe
    El-Rifai, Wa'el
    Peng, Dunfa
    Ruemmele, Petra
    Kroeckel, Ivonne
    Peters, Brigitte
    Moskaluk, Christopher A.
    Stolte, Manfred
    Moenkemueller, Klaus
    Meyer, Frank
    Schulz, Hans-Ulrich
    Hartmann, Arndt
    Roessner, Albert
    Schneider-Stock, Regine
    [J]. CANCER LETTERS, 2009, 275 (01) : 117 - 126
  • [3] Does inflammation lead to activation of CDX2 and the metaplasia-dysplasia-carcinoma sequence progression in Barrett's oesophagus and oesophageal adenocarcinoma?
    Atie, M.
    Sabah, M.
    Broe, P.
    Hays, D. B. Bouchier
    Kay, E.
    Walsh, T. N.
    [J]. BRITISH JOURNAL OF SURGERY, 2010, 97 : 12 - 12
  • [4] Alterations of the Y chromosome in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus
    Sarbia, M.
    Hofler, H.
    Geddert, H.
    Stein, H.
    Langner, C.
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 358 - 358
  • [5] Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence
    Theisen, J
    Nigro, JJ
    DeMeester, TR
    Peters, JH
    Gastal, OL
    Hagen, JA
    Hashemi, M
    Bremner, CG
    [J]. DISEASES OF THE ESOPHAGUS, 2004, 17 (01) : 67 - 70
  • [6] Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus
    Geddert, H
    Heep, HJ
    Gabbert, HE
    Sarbia, M
    [J]. CANCER, 2002, 94 (01) : 212 - 218
  • [7] Barrett's esophagus:: genetic alterations in the metaplasia-dysplasia-carcinoma sequence detected by CGH
    Walch, A
    Zitzelsberger, H
    Bruch, J
    Keller, G
    Angermeier, D
    Aubele, M
    Mueller, J
    Stein, H
    Braselmann, H
    Siewert, J
    Höfler, H
    Werner, M
    [J]. 2ND INTERNATIONAL CONGRESS ON GASTROENTEROLOGICAL CARCINOGENESIS, 1999, : 23 - 26
  • [8] Role of S100β protein in metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus
    D'Alessandro, A.
    Esposito, G.
    Pesce, M.
    Cargiolli, M.
    Zito, F. P.
    Seguella, L.
    Gigli, S.
    De Palma, G. D.
    Cuomo, R.
    Sarnelli, G.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 : 13 - 13
  • [9] Barrett's esophagus: Disregulation of cell cycling and intercellular adhesion in the metaplasia-dysplasia-carcinoma sequence
    Tselepis, C
    Perry, I
    Jankowski, J
    [J]. DIGESTION, 2000, 61 (01) : 1 - 5
  • [10] Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence
    Hayes, Stephen
    Ahmed, Sajad
    Clark, Peter
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (02) : 110 - 113